National Comprehensive Cancer Network



About NCCN

Head and Neck Cancers Panel - Disclosures as of 2/28/2014

View NCCN Management Team Disclosures | View NCCN Guidelines Staff Disclosures | View NCCN ORP Staff Disclosures

Panel Member Clinical Research Support/Data Safety Monitoring Board Scientific Advisory Boards, Consultant, or Expert Witness Promotional Advisory Boards, Consultant, or Speakers Bureau Employment/ Governing Board, Patent, Equity, or Royalty Spouse/Domestic Partner/Dependent Potential Conflict Date Completed

David M. Brizel, MD

None

medical legal case unrelated to any nccn activities

None

None

None

6/16/2014

Paul M. Busse, MD, PhD

None

None

None

None

None

8/18/2014

Jimmy J. Caudell, MD, PhD

None

Boehringer Ingelheim GmbH

None

None

None

6/5/2014

Anthony J. Cmelak, MD

None

Amgen Inc.

None

None

None

6/5/2014

A. Dimitrios Colevas, MD

Bayer HealthCare;
Boehringer Ingelheim GmbH;
Exelixis Inc.;
Genentech, Inc.;
GlaxoSmithKline;
actogenix;
ecog;
NCI;
rtog

None

None

None

None

6/4/2014

Frank Dunphy, MD

Bristol-Myers Squibb Company

None

None

None

None

5/22/2014

David W. Eisele, MD, FACS

None

None

None

None

None

2/11/2015

Lauren Gallagher, RPh, PhD

None

None

None

None

None

12/8/2014

Jill Gilbert, MD

National Cancer Institute;
Eastern Cooperative Oncology Group

None

None

None

None

6/9/2014

Maura L. Gillison, MD, PhD

None

None

None

None

None

8/1/2014

Kristina M. Gregory, RN, MSN, OCN

None

None

None

None

None

9/16/2014

Robert I. Haddad, MD

None

None

None

None

None

2/27/2015

Bruce H. Haughey, MBChB, MS

None

None

None

None

None

5/29/2014

Wesley L. Hicks, MD

None

None

None

None

None

7/11/2014

Ying J. Hitchcock, MD

None

None

None

None

None

6/10/2014

Miranda Hughes, PhD

None

None

None

None

None

11/7/2014

Antonio Jimeno, MD, PhD

Boehringer Ingelheim GmbH;
Genentech, Inc.;
Oncothyreon;
VentiRX Pharmaceuticals

None

None

None

None

6/9/2014

Merrill S. Kies, MD

None

None

None

None

None

1/11/2014

William M. Lydiatt, MD

None

None

None

None

None

2/26/2015

Ellie Maghami, MD

None

None

None

None

None

2/11/2015

Renato Martins, MD, MPH

None

None

None

None

None

2/10/2015

Thomas McCaffrey, MD, PhD

None

None

None

None

None

6/5/2012

Joan S. McClure, MS

None

None

None

None

None

12/8/2014

Nicole McMillian, MS

None

None

None

None

None

10/8/2014

Loren K. Mell, MD

None

None

None

None

None

5/1/2014

Bharat B. Mittal, MD

None

None

None

None

None

5/12/2014

David G. Pfister, MD

AstraZeneca Pharmaceuticals LP;
Boehringer Ingelheim GmbH;
Eli Lilly and Company;
Exelixis Inc.;
Genentech, Inc.;
Novartis Pharmaceuticals Corporation

None

None

None

None

5/29/2014

Harlan A. Pinto, MD

Bristol-Myers Squibb Company

Eli Lilly and Company

None

None

None

8/9/2014

John A. Ridge, MD, PhD, FACS

None

None

None

None

None

2/26/2015

Sandeep Samant, MD

None

None

None

None

None

7/1/2014

David E. Schuller, MD

None

None

None

National Cancer Institute

None

3/20/2013

Jatin P. Shah, MD, PhD

None

None

None

None

None

2/25/2015

Sharon Spencer, MD

None

None

None

None

None

2/5/2015

Sarika Trikha, PharmD

None

None

None

None

None

11/11/2014

Randal S. Weber, MD

None

None

None

None

None

6/5/2014

Gregory Wolf, MD

None

None

None

None

None

5/2/2014

Frank Worden, MD

Pfizer Inc.

Bristol-Myers Squibb Company

Baxter International Inc.;
Bristol-Myers Squibb Company;
Onyx Pharmaceuticals, Inc.

None

None

1/10/2014

Sue S. Yom, MD, PhD

Genentech, Inc.

None

None

None

None

5/4/2014